John W Beck - Net Worth and Insider Trading

John W Beck Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, John W Beck owns 4 companies in total, including Ritter Pharmaceuticals Inc (RTTR) , Artelo Biosciences Inc (ARTL) , and Metabasis Therapeutics Inc (LGNZZ) among others .

Click here to see the complete history of John W Beck’s form 4 insider trades.

Insider Ownership Summary of John W Beck

Ticker	Comapny	Transaction Date	Type of Owner
RTTR	Ritter Pharmaceuticals Inc	2020-05-18	Chief Financial Officer
ARTL	Artelo Biosciences Inc	2019-12-06	director
LGNZZ	Metabasis Therapeutics Inc	2008-04-02	Chief Financial Officer
		2018-05-23	Chief Financial Officer

John W Beck Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

John W Beck Ownership Network

Ownership Network List of John W Beck

No Data

Ownership Network Relation of John W Beck

John W Beck Owned Company Details

What does Ritter Pharmaceuticals Inc do?

Who are the key executives at Ritter Pharmaceuticals Inc?

John W Beck is the Chief Financial Officer of Ritter Pharmaceuticals Inc. Other key executives at Ritter Pharmaceuticals Inc include 10 percent owner Sekisui Diagnostics, Llc , director & Chairman & President & CEO Michael S. Poirier , and Vice President of Finance & CFO Christopher L. Lotz .

Ritter Pharmaceuticals Inc (RTTR) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Ritter Pharmaceuticals Inc (RTTR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ritter Pharmaceuticals Inc (RTTR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Ritter Pharmaceuticals Inc (RTTR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Ritter Pharmaceuticals Inc Insider Transactions

No Available Data

What does Artelo Biosciences Inc do?

Who are the key executives at Artelo Biosciences Inc?

John W Beck is the director of Artelo Biosciences Inc. Other key executives at Artelo Biosciences Inc include director & See Remarks Gregory D. Gorgas , 10 percent owner David J Moss , and 10 percent owner Peter Michael O'brien .

Artelo Biosciences Inc (ARTL) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Artelo Biosciences Inc (ARTL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Artelo Biosciences Inc (ARTL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Artelo Biosciences Inc (ARTL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Artelo Biosciences Inc Insider Transactions

No Available Data

What does Metabasis Therapeutics Inc do?

Who are the key executives at Metabasis Therapeutics Inc?

John W Beck is the Chief Financial Officer of Metabasis Therapeutics Inc. Other key executives at Metabasis Therapeutics Inc include 10 percent owner Mpm Asset Management Investors 2000b Llc , 10 percent owner Mpm Asset Management Ii Llc , and 10 percent owner Mpm Asset Management Ii Lp .

Metabasis Therapeutics Inc (LGNZZ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Metabasis Therapeutics Inc (LGNZZ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Metabasis Therapeutics Inc (LGNZZ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Metabasis Therapeutics Inc (LGNZZ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Metabasis Therapeutics Inc Insider Transactions

No Available Data

What does Qualigen Therapeutics Inc do?

Who are the key executives at Qualigen Therapeutics Inc?

John W Beck is the Chief Financial Officer of Qualigen Therapeutics Inc. Other key executives at Qualigen Therapeutics Inc include director & Chairman & President and CEO Michael S. Poirier , SVP/Chief Medical Officer Tariq Arshad , and Vice President of Finance & CFO Christopher L. Lotz .

Qualigen Therapeutics Inc (QLGN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Qualigen Therapeutics Inc (QLGN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Qualigen Therapeutics Inc (QLGN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Qualigen Therapeutics Inc (QLGN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Qualigen Therapeutics Inc Insider Transactions

No Available Data

John W Beck Mailing Address

Above is the net worth, insider trading, and ownership report for John W Beck. You might contact John W Beck via mailing address: C/o Ritter Pharmaceuticals, Inc., 1880 Century Park East, Suite 1000, Los Angeles Ca 90067.

Discussions on John W Beck

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.